Birthweight and risk of type 1 diabetes in children and young adults: a population-based register study

G G Dahlquist1, A Pundziūte-Lyckå, L Nyström

  • 1Department of Clinical Sciences, Paediatrics, Umeå University, 90185, Umeå, Sweden. Gisela.Dahlquist@pediatri.umu.se

Diabetologia
|May 3, 2005
PubMed

Insights

Type 1 diabetes risk is linked to birthweight, but only for children who develop the disease before age 10. This association is not significant for later onset type 1 diabetes (T1D).

Area of Science:

  • Pediatrics
  • Endocrinology
  • Epidemiology

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease with increasing incidence globally.
  • Understanding risk factors, including prenatal and perinatal influences, is crucial for prevention strategies.

Purpose of the Study:

  • To investigate the association between birthweight and the risk of developing type 1 diabetes.
  • To examine if this association varies by age at disease onset.

Main Methods:

  • A population-based case-referent study utilizing linked Swedish nationwide registers.
  • Included incident cases of type 1 diabetes aged 0-14 and 15-34 years, with birth data from the Swedish Medical Birth Registry.
  • Birthweight was analyzed as standard deviation scores (SDS), adjusted for relevant covariates.

Main Results:

  • A significant inverse linear trend was observed between birthweight SDS and type 1 diabetes risk for cases with onset before 10 years of age (OR per SDS: 0.062).
  • No significant trend was found for type 1 diabetes cases with onset between 10 and 29 years of age (OR per SDS: 0.004).

Conclusions:

  • The association between birthweight and type 1 diabetes risk is primarily evident in individuals with early-onset disease.
  • These findings suggest distinct etiological pathways for early- versus later-onset type 1 diabetes.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...